domingo, 8 de junio de 2014

Preventing Chronic Disease | Hypertension Prevalence, Awareness, Treatment, and Control and Sodium Intake in Shandong Province, China: Baseline Results From Shandong–Ministry of Health Action on Salt Reduction and Hypertension (SMASH), 2011 - CDC

full-text ►

Preventing Chronic Disease | Hypertension Prevalence, Awareness, Treatment, and Control and Sodium Intake in Shandong Province, China: Baseline Results From Shandong–Ministry of Health Action on Salt Reduction and Hypertension (SMASH), 2011 - CDC



Image of eCard



Preventing Chronic Disease Logo



Hypertension Prevalence, Awareness, Treatment, and Control and Sodium Intake in Shandong Province, China: Baseline Results From Shandong–Ministry of Health Action on Salt Reduction and Hypertension (SMASH), 2011

Zhenqiang Bi, PhD; Xiaofeng Liang, MS; Aiqiang Xu, PhD; Linghong Wang, MS; Xiaoming Shi, PhD; Wenhua Zhao, PhD; Jixiang Ma, PhD; Xiaolei Guo, MS; Xiaofei Zhang, PhD; Jiyu Zhang, MS; Jie Ren, MS; Liuxia Yan, MS; Zilong Lu, MS; Huicheng Wang, MS; Junli Tang, MS; Xiaoning Cai, MS; Jing Dong, MS; Juan Zhang, PhD; Jie Chu, PhD; Michael Engelgau, MD; Quanhe Yang, PhD; Yuling Hong, MD, PhD; Yu Wang, PhD

Suggested citation for this article: Bi Z, Liang X, Xu A, Wang L, Shi X, Zhao W, et al. Hypertension Prevalence, Awareness, Treatment, and Control and Sodium Intake in Shandong Province, China: Baseline Results From Shandong–Ministry of Health Action on Salt Reduction and Hypertension (SMASH), 2011. Prev Chronic Dis 2014;11:130423. DOI: http://dx.doi.org/10.5888/pcd11.130423External Web Site Icon.
PEER REVIEWED

Abstract

Introduction
In China, population-based blood pressure levels and prevalence of hypertension are increasing. Meanwhile, sodium intake, a major risk factor for hypertension, is high. In 2011, to develop intervention priorities for a salt reduction and hypertension control project in Shandong Province (population 96 million), a cross-sectional survey was conducted to collect information on sodium intake and hypertension prevalence, awareness, treatment, and control.
Methods
Complex, multistage sampling methods were used to select a provincial-representative adult sample. Blood pressure was measured and a survey conducted among all participants; condiments were weighed in the household, a 24-hour dietary recall was conducted, and urine was collected. Hypertension was determined by blood pressure measured on a single occasion and self-reported use of antihypertension medications.
Results
Overall, 23.4% (95% confidence interval [CI], 20.9%–26.0%) of adults in Shandong were estimated to have hypertension. Among those classified as having hypertension, approximately one-third (34.5%) reported having hypertension, approximately one-fourth (27.5%) reported taking medications, and one-seventh (14.9%) had their blood pressure controlled (<140/<90 mm Hg). Estimated total average daily dietary sodium intake was 5,745 mg (95% CI, 5,428 mg–6,063 mg). Most dietary sodium (80.8%) came from salt and high-salt condiments added during cooking: a sodium intake of 4,640 mg (95% CI, 4,360 mg–4,920 mg). The average daily urinary sodium excretion was 5,398 mg (95% CI, 5,112 mg–5,683 mg).
Conclusion
Hypertension and excessive sodium intake in adults are major public health problems in Shandong Province, China.
Maps
Figure 1. Location of the sampled countries/districts in Shandong Province, China, Shandong–Ministry of Health Action on Salt Reduction and Hypertension baseline survey, 2011. [A text description of this figure is also available.]

Author Information

Corresponding Author: Yu Wang, PhD, Chinese Center for Disease Control and Prevention, 155 Changbai Rd, Changping District, Beijing, 102206, People’s Republic of China. Telephone: 86-10-58900301. E-mail: wangyu@chinacdc.cn.
Author Affiliations: Zhenqiang Bi, Aiqiang Xu, Xiaolei Guo, Jiyu Zhang, Jie Ren, Zilong Lu, Junli Tang, Jing Dong, Jie Chu, Academy of Preventive Medicine, Shandong University, Jinan, China, and Shandong Center for Disease Control and Prevention, Jinan, China; Xiaofeng Liang, Xiaoming Shi, Wenhua Zhao, Huicheng Wang, Juan Zhang, Chinese Center for Disease Control and Prevention, Beijing, China; Linghong Wang, Jixiang Ma, Liuxia Yan, Xiaoning Cai, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China; Xiaofei Zhang, Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, China; Michael Engelgau, Quanhe Yang, Yuling Hong, Centers for Disease Control and Prevention, Atlanta, Georgia.

References

  1. Wang LD. Nutrition and health status in Chinese people. Beijing (CN): People’s Publishing House; 2005.
  2. Huang JS. The summary report of the National Symposium on Heart and Vascular Diseases. The collection of scientific reports on the National Symposium on Heart and Vascular Diseases. Beijing (CN): People’s Publishing House; 1960.
  3. Anderson CA, Appel LJ, Okuda N, Brown IJ, Chan Q, Zhao L, et al. Dietary sources of sodium in China, Japan, the United Kingdom, and the United States, women and men aged 40 to 59 years: the INTERMAP study. J Am Diet Assoc 2010;110(5):736–45. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  4. Du S, Neiman A, Batis C, Wang H, Zhang B, Zhang J, et al. Understanding the patterns and trends of sodium intake, potassium intake, and sodium to potassium ratio and their effect on hypertension in China. Am J Clin Nutr 2014;99(2):334–43. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  5. China’s Bureau of Disease Control and Prevention Ministry of Health and China CDC [brochure]. China NCD Report 2011. Beijing (CN); 2011.
  6. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010;362(7):590–9. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  7. Tuomilehto J, Jousilahti P, Rastenyte D, Moltchanov V, Tanskanen A, Pietinen P, et al. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet 2001;357(9259):848–51. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  8. Chinese Center for Disease Control and Prevention. Overall protocols of Chinese Behavioral Risk Factor Surveillance in 2010. http://www.chinacdc.cn/n272442/n272530/n3479265/n3479306/appendix/attach.pdf. Accessed November 27, 2013.
  9. Zhai F, Guo X, Popkin BM, Ma L, Wang Q, Yu W, et al. Evaluation of the 24-hour individual recall method in China. Food Nutr Bull 1996;17(2):154–61.
  10. Institution of Nutrition and Food Safety, Chinese Center for Disease Control and Prevention. China food composition 2004 book 2. Beijing (CN): Beijing Medical University Press; 2005.
  11. Elliott P, Brown I. Sodium intakes around the world. http://www.who.int/dietphysicalactivity/Elliot-brown-2007.pdf. Accessed November 27, 2013.
  12. Medical Administration Department of Ministry of Public Health. People’s Republic of China. National guide on clinical laboratory procedures, 3rd edition. Nanjing (CN): Southeast University Publishing House; 2009.
  13. Liu LS, Writing Group of 2010 Chinese Guidelines for the Management of Hypertension. 2010 Chinese guidelines for the management of hypertension. Chin J Cardiol 2011;39(7):579–615. PubMedExternal Web Site Icon
  14. Ciol MA, Hoffman JM, Dudgeon BJ, Shumway-Cook A, Yorkston KM, Chan L. Understanding the use of weights in the analysis of data from multistage surveys. Arch Phys Med Rehabil 2006;87(2):299–303. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  15. China’s Bureau of Disease Control and Prevention Ministry of Health. Guideline on overweight and obesity control and prevention in China. Beijing (CN): People’s Medical Publishing House; 2006.
  16. Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation 2008;118(25):2679–86. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  17. Zhao Y, Lu F, Sun H, Liu Z, Zhao Y, Sun S, et al. Trends in hypertension prevalence, awareness, treatment, and control rates in Shandong Province of China. J Clin Hypertens (Greenwich) 2012;14(9):637–43. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  18. Yang J, Lu F, Zhang C, Liu Z, Zhao Y, Gao F, et al. Prevalence of prehypertension and hypertension in a Chinese rural area from 1991 to 2007. Hypertens Res 2010;33(4):331–7. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  19. Ma YQ, Mei WH, Yin P, Yang XH, Rastegar SK, Yan JD. Prevalence of hypertension in Chinese cities: a meta-analysis of published studies. PLoS ONE 2013;8(3):e58302. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  20. Li YC, Wang LM, Jiang Y, Li XY, Zhang M, Hu N. Prevalence of hypertension among Chinese adults in 2010. Chin J Prev Med 2012;46(5):409–13.PubMedExternal Web Site Icon
  21. Ma GS, Li YP, Wu YF, Zhai FY, Cui ZH, Hu XQ, et al. The prevalence of body overweight and obesity and its changes among Chinese people during 1992 to 2002. Chin J Prev Med 2005;39(5):311–5. PubMedExternal Web Site Icon
  22. Olives C, Myerson R, Mokdad AH, Murray CJ, Lim SS. Prevalence, awareness, treatment, and control of hypertension in United States counties, 2001–2009. PLoS ONE 2013;8(4):e60308. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  23. Prince MJ, Ebrahim S, Acosta D, Ferri CP, Guerra M, Huang Y, et al. Hypertension prevalence, awareness, treatment and control among older people in Latin America, India and China: a 10/66 cross-sectional population-based survey. J Hypertens 2012;30(1):177–87. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  24. Xia H, Li H, Wang WF, Zheng WG, Meng QY. Studying the rate of awareness, treatment and control of hypertension and its influential factors among rural residents in Shandong Province. Chin Health Serv Manage 2008;25(9):614–6.
  25. Li N, Yan LL, Niu W, Labarthe D, Feng X, Shi J, et al. A large-scale cluster randomized trial to determine the effects of community-based dietary sodium reduction — the China Rural Health Initiative Sodium Reduction Study. Am Heart J 2013;166(5):815–22. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  26. Liem DG, Miremadi F, Keast RSJ. Reducing sodium in foods: the effect on flavor. Nutrients 2011;3(6):694–711. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  27. Girgis S, Neal B, Prescott J, Prendergast J, Dumbrell S, Turner C, et al. A one-quarter reduction in the salt content of bread can be made without detection. Eur J Clin Nutr 2003;57(4):616–20. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  28. He FJ, Brinsden HC, Macgregor GA. Salt reduction in the United Kingdom: a successful experiment in public health. J Hum Hypertens 2013. CrossRefExternal Web Site IconPubMedExternal Web Site Icon
  29. Bentley B. A review of methods to measure dietary sodium intake. J Cardiovasc Nurs 2006;21(1):63–7. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  30. Murakami K, Sasaki S, Takahashi Y, Uenishi K, Watanabe T, Kohri T, et al. Sensitivity and specificity of published strategies using urinary creatinine to identify incomplete 24-h urine collection. Nutrition 2008;24(1):16–22. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  31. The Seventh Report of the Joint National Committee on Prevention. Detection, evaluation, and treatment of high blood pressure. http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.pdf. Accessed March 3, 2014.

No hay comentarios: